These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2096172)

  • 1. "Designer drugs"--a current perspective.
    Jerrard DA
    J Emerg Med; 1990; 8(6):733-41. PubMed ID: 2096172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving high: new designer drugs of abuse.
    Pourmand A; Armstrong P; Mazer-Amirshahi M; Shokoohi H
    Hum Exp Toxicol; 2014 Oct; 33(10):993-9. PubMed ID: 24501103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Designer drugs'. Recognizing and managing their toxic effects.
    Sternbach GL; Varon J
    Postgrad Med; 1992 Jun; 91(8):169-71, 175-6. PubMed ID: 1603749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse: the designer drugs.
    Beebe DK; Walley E
    Am Fam Physician; 1991 May; 43(5):1689-98. PubMed ID: 2021104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Designer drugs'. A problem in clinical toxicology.
    Buchanan JF; Brown CR
    Med Toxicol Adverse Drug Exp; 1988; 3(1):1-17. PubMed ID: 3285124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of commercial immunoassays for screening of new amphetamine designer drugs. A review.
    Nieddu M; Baralla E; Pasciu V; Rimoli MG; Boatto G
    J Pharm Biomed Anal; 2022 Sep; 218():114868. PubMed ID: 35688007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxic effects of designer drugs: synthetic is not better!
    Luciano RL; Perazella MA
    Nat Rev Nephrol; 2014 Jun; 10(6):314-24. PubMed ID: 24662435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry, pharmacology, and metabolism of emerging drugs of abuse.
    Maurer HH
    Ther Drug Monit; 2010 Oct; 32(5):544-9. PubMed ID: 20683389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs.
    Misselbrook GP; Hamilton EJ
    Acute Med; 2012; 11(3):157-60. PubMed ID: 22993747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stalking the elusive designer drugs: techniques for monitoring new problems in drug abuse.
    Ruttenber AJ
    J Addict Dis; 1991; 11(1):71-87. PubMed ID: 1790155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An expanding world of new psychoactive substances-designer benzodiazepines.
    Zawilska JB; Wojcieszak J
    Neurotoxicology; 2019 Jul; 73():8-16. PubMed ID: 30802466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clandestine drug laboratory situation in the United States.
    Frank RS
    J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical complications of drug abuse.
    Chiang W; Goldfrank L
    Med J Aust; 1990 Jan; 152(2):83-8. PubMed ID: 2404189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
    Betzler F; Heinz A; Köhler S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
    [No Abstract]   [Full Text] [Related]  

  • 17. A Case of Unusual Drug Screening Results.
    Chang BN; Smith MP
    Clin Chem; 2017 May; 63(5):958-961. PubMed ID: 28455300
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced psychoses.
    Hurlbut KM
    Emerg Med Clin North Am; 1991 Feb; 9(1):31-52. PubMed ID: 2001668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands.
    de Jong LAA; Olyslager EJH; Duijst WLJM
    J Forensic Leg Med; 2019 Jul; 65():101-104. PubMed ID: 31129558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.